None
Quote | Scancell Holdings Plc Ord (OTCMKTS:SCNLF)
Last: | $0.127 |
---|---|
Change Percent: | 0.0% |
Open: | $0.127 |
Close: | $0.127 |
High: | $0.127 |
Low: | $0.127 |
Volume: | 1,500 |
Last Trade Date Time: | 01/10/2024 03:00:00 am |
News | Scancell Holdings Plc Ord (OTCMKTS:SCNLF)
(NewsDirect) Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the initial phase of the clinical stage biopharmaceutical company's Phase 2 SCOPE trial in advanced melanoma. Professor Durra...
(NewsDirect) Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the clinical stage biopharmaceutical company's progress and financial position. Durrant starts by highlighting that Scancel...
Message Board Posts | Scancell Holdings Plc Ord (OTCMKTS:SCNLF)
Subject | By | Source | When |
---|---|---|---|
Moditope eradicates aggressive melanoma in transgenic mice | Gift_Horse | investorshub | 05/08/2014 1:09:17 AM |
Banshee Buckaroo: Moditope eradicates aggressive melanoma in transgenic mice Moditope is a brand new | Banshee Buckaroo | investorshangout | 05/06/2014 4:39:20 AM |
Banshee Buckaroo: Scancell to give AACR presentation on SCIB1 vaccine Scancell is to present | Banshee Buckaroo | investorshangout | 04/07/2014 12:57:36 AM |
Scancell to give AACR presentation on SCIB1 vaccine | Blue Fire | investorshub | 04/05/2014 12:52:21 AM |
Banshee Buckaroo: Scancell's remarkable history of success 28 March 2014| by MarsBarsAtDawnScancell, | Banshee Buckaroo | investorshangout | 03/28/2014 6:19:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Scancell Holdings Plc Ord Company Name:
SCNLF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the initial phase of the clinical stage biopharmaceutical company's Phase 2 SCOPE trial in advanced melanoma. Professor Durra...
(NewsDirect) Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on the clinical stage biopharmaceutical company's progress and financial position. Durrant starts by highlighting that Scancel...